Data-driven decision-making, evolving access models, and accelerating adoption of AI create a complex commercialization landscape.
Mark Thierer
Advertisement
Mark Thierer is CEO of EVERSANA.
Articles by Mark Thierer
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
UCB Enters $2.2 Billion Agreement to Acquire Candid Therapeutics
2
How a Shifting Landscape is Making Affordable DTP At Scale a Reality
3
Global Disruptions to the Pharma Supply Chain: Q&A with Jeff Golfman
4
Sanofi Officially Appoints Belén Garijo as Chief Executive Officer Following Shareholder Vote
5